[HTML][HTML] Galactose in human metabolism, glycosylation and congenital metabolic diseases: Time for a closer look
F Conte, N van Buuringen, NC Voermans… - Biochimica et Biophysica …, 2021 - Elsevier
Galactose is an essential carbohydrate for cellular metabolism, as it contributes to energy
production and storage in several human tissues while also being a precursor for …
production and storage in several human tissues while also being a precursor for …
Current and future prospects for gene therapy for rare genetic diseases affecting the brain and spinal cord
TL Jensen, CR Gøtzsche… - Frontiers in molecular …, 2021 - frontiersin.org
In recent years, gene therapy has been raising hopes toward viable treatment strategies for
rare genetic diseases for which there has been almost exclusively supportive treatment. We …
rare genetic diseases for which there has been almost exclusively supportive treatment. We …
[HTML][HTML] The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?
NJ Weinreb, O Goker-Alpan, PS Kishnani… - Molecular genetics and …, 2022 - Elsevier
Gaucher disease (GD) is an autosomal recessive inherited lysosomal storage disease that
often presents in early childhood and is associated with damage to multiple organ systems …
often presents in early childhood and is associated with damage to multiple organ systems …
CNS-targeting therapies for lysosomal storage diseases: current advances and challenges
MJ Edelmann, GHB Maegawa - Frontiers in molecular biosciences, 2020 - frontiersin.org
During the past decades, several therapeutic approaches have been developed and made
rapidly available for many patients afflicted with lysosomal storage disorders (LSDs), inborn …
rapidly available for many patients afflicted with lysosomal storage disorders (LSDs), inborn …
Diagnosis of mucopolysaccharidoses
F Kubaski, F de Oliveira Poswar, K Michelin-Tirelli… - Diagnostics, 2020 - mdpi.com
The mucopolysaccharidoses (MPSs) include 11 different conditions caused by specific
enzyme deficiencies in the degradation pathway of glycosaminoglycans (GAGs). Although …
enzyme deficiencies in the degradation pathway of glycosaminoglycans (GAGs). Although …
Krabbe disease: globoid cell leukodystrophy
DA Wenger, P Luzi - Rosenberg's molecular and genetic basis of …, 2025 - Elsevier
Krabbe disease or globoid cell leukodystrophy (GLD) is an autosomal recessive disorder of
myelination caused by the deficiency of galactocerebrosidase (GALC) activity. This enzyme …
myelination caused by the deficiency of galactocerebrosidase (GALC) activity. This enzyme …
Long-term neurodevelopmental outcomes of hematopoietic stem cell transplantation for late-infantile Krabbe disease
IC Yoon, NA Bascou, MD Poe… - Blood, The Journal …, 2021 - ashpublications.org
Krabbe disease is a rare neurodegenerative disorder caused by a deficiency in
galactocerebrosidase. The only effective treatment is hematopoietic stem cell transplantation …
galactocerebrosidase. The only effective treatment is hematopoietic stem cell transplantation …
[HTML][HTML] The critical role of psychosine in screening, diagnosis, and monitoring of Krabbe disease
AJ Guenzel, CT Turgeon, KK Nickander, AL White… - Genetics in …, 2020 - Elsevier
Purpose Newborn screening (NBS) for Krabbe disease (KD) is performed by measurement
of galactocerebrosidase (GALC) activity as the primary test. This revealed that GALC activity …
of galactocerebrosidase (GALC) activity as the primary test. This revealed that GALC activity …
Newborn screening is on a collision course with public health ethics
RJ Currier - International Journal of Neonatal Screening, 2022 - mdpi.com
Newborn screening was established over 50 years ago to identify cases of disorders that
were serious, urgent, and treatable, mirroring the criteria of Wilson and Jungner. In the last …
were serious, urgent, and treatable, mirroring the criteria of Wilson and Jungner. In the last …
A prospective natural history study of Krabbe disease in a patient cohort with onset between 6 months and 3 years of life
N Bascou, A DeRenzo, MD Poe, ML Escolar - Orphanet journal of rare …, 2018 - Springer
Background Krabbe disease is a rare neurodegenerative disorder caused by a deficiency in
the lysosomal enzyme galactocerebrosidase. Patients with Krabbe disease present with a …
the lysosomal enzyme galactocerebrosidase. Patients with Krabbe disease present with a …